Development and Validation of the Framingham Steatosis Index to Identify Persons With Hepatic Steatosis.

@article{Long2016DevelopmentAV,
  title={Development and Validation of the Framingham Steatosis Index to Identify Persons With Hepatic Steatosis.},
  author={Michelle T Long and Alison Pedley and Lisandro D Colantonio and Joseph M. Massaro and Udo Hoffmann and Paul Muntner and Caroline Fox},
  journal={Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association},
  year={2016},
  volume={14 8},
  pages={
          1172-1180.e2
        }
}
BACKGROUND & AIMS Serum levels of aminotransferases are used as markers of nonalcoholic fatty liver disease in epidemiology research. However, it is not clear whether they can be used to identify patients with fatty liver. We investigated the accuracy of serum levels of aminotransferases in detection of hepatic steatosis. In addition, we derived a Framingham steatosis index (FSI) and tested its ability to identify patients with hepatic steatosis in an independent cohort. METHODS We performed… CONTINUE READING
Related Discussions
This paper has been referenced on Twitter 5 times. VIEW TWEETS

References

Publications referenced by this paper.
Showing 1-10 of 27 references

Similar Papers

Loading similar papers…